Form 4 for IMCR Immunocore Holdings plc
Accepted 2024-01-05 00:00:00 ET · period of report 2024-01-03 · accession 0001209191-24-001014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-05 | 2024-01-03 | IMCR | St Leger Tina Amber | Chief HR Off | S - Sale+OE | $69.89 | -4,375 | 307 | -93% | -$305.8K |
| D | 2024-01-05 | 2024-01-03 | IMCR | St Leger Tina Amber | Chief HR Off | M - OptEx | $29.87 | +4,375 | 4,375 | New | +$130.7K |
| D | 2024-01-05 | 2024-01-03 | IMCR | St Leger Tina Amber | Chief HR Off | M - OptEx | $0.00 | -4,375 | 39.4K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-01-03 | S | D | 307 | $70.46 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.40 to $70.66 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Ordinary Shares | 2024-01-03 | S | D | 4,068 | $69.85 | 307 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.28 to $70.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Ordinary Shares | 2024-01-03 | M | A | 4,375 | $29.87 | 4,375 | D | — | — | |
| 4 | Derivative | Employee Share Option (Right to Buy) | 2024-01-03 | M | D | 4,375 | $0.00 | 39,375 | D | $29.87 · — to 2032-03-31 | 4,375 Ordinary Shares | (F4) 25% of the shares subject to the option award vested on April 1, 2023, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. |